EBV SPECIFIC T-LYMPHOCYTES
Showing 1 - 25 of >10,000
EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:
Not yet recruiting
- EBV-Related Hodgkin Lymphoma
- +2 more
- Dose Level 1A: 2 x 10^7 cells/m2
- +4 more
-
Houston, Texas
- +1 more
Feb 7, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)
Active, not recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, ThessalonÃki
Recruiting
- Opportunistic Fungal Infection
- +2 more
- Pentavalent-specific T cells (penta-STs)
-
Patra, Greece
- +1 more
Jul 26, 2022
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)
Terminated
- Serologically Active Adult Systemic Lupus Erythematosus
- Autologous EBV specific CTL infusion
-
Nantes, France
- +2 more
Mar 24, 2022
EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,
Recruiting
- EBV Associated Extranodal NK/T-cell Lymphoma
- EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
- EBViNT Cell
-
Seoul, Gangnam-gu, Korea, Republic of
- +7 more
Jul 7, 2022
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)
Completed
- Epstein-Barr Virus Infections
- +2 more
- Cytotoxic T Lymphocytes
-
Milwaukee, WisconsinMedical College of Wisconsin
Oct 21, 2021
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)
Recruiting
- Multiple Sclerosis
- Cellular therapy with EBV specific autologous CTL infusion
-
Nantes, FranceUniversity Hospital
Jan 27, 2021
Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)
Not yet recruiting
- Adenovirus
- +2 more
- Specific T- Lymphocytes
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Sep 8, 2023
Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,
Terminated
- Acute Myeloid Leukemia
- +4 more
- Aldesleukin
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 15, 2021
Neuroblastoma Trial in Houston (EBV specific CTLs)
Active, not recruiting
- Neuroblastoma
- EBV specific CTLs
-
Houston, TexasTexas Children's Hospital
Feb 2, 2022
Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)
Recruiting
- Epstein-Barr Virus Infections
- +2 more
- Group A
- Group B
-
Montreal, Quebec, CanadaHôpital Maisonneuve-Rosemont
Apr 5, 2022
Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)
Recruiting
- Adenovirus Infection
- Adenovirus Specific T lymphocytes
-
Columbus, OhioNationwide Children's Hospital
Sep 1, 2022
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm
Not yet recruiting
- EBV Lymphoma
- Post-transplant Lymphoproliferative Disease (PTLD)
- Donor-derived ex-vivo expanded EBV Tscm CTL
-
Basel, Switzerland
- +7 more
Jan 25, 2023
Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)
Recruiting
- Hodgkins Lymphoma
- Non Hodgkins Lymphoma
- TAA-specific CTLs
-
Houston, TexasTexas Children's Hospital
Jul 14, 2022
Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))
Recruiting
- Solid Tumor
- Tumor-associated antigen-specific T cell (TAA-T)
-
Washington, District of ColumbiaChildren's National Hospital
Oct 24, 2022
Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)
Recruiting
- Multiple Myeloma
- TAA-specific CTLs
- TAA-specific CTLs- fixed dose
-
Houston, TexasHouston Methodist Hospital
Nov 11, 2022
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- autologous or syngeneic PBTLs and EBV-CTLs
-
Houston, Texas
- +1 more
Feb 6, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023